Dr Reddys Laboratories RDY
NYSE RDY
$11.85 -0.03 (-0.21%)
As of: Sep 9, 2026 · 3:07 PM EDT

Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Asset Utilization Ratio of 0.59 for Q2 2026, down 1.94% on a QoQ basis from 0.6 in Q1 2026, and down 11.6% year-over-year from 0.67 in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Asset Utilization Ratio (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.59 in Q2 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 11.6% year-over-year to 0.59 in Q2 2026; TTM through Jun 2026 was 0.59, a 11.6% decrease from a year earlier, with the FY2026 full-year figure at 0.6, down 18.92% from the prior year.
  • Asset Utilization Ratio was 0.59 for Q2 2026 at Dr Reddys Laboratories, down from 0.6 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.81 in Q2 2023, with the low at 0.59 in Q2 2026.
  • Average Asset Utilization Ratio over 5 years is 0.71, with a median of 0.72 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio advanced 10.91% in 2023, then declined 14.14% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.81 in 2022, then decreased by 4.58% to 0.77 in 2023, then slipped by 14.14% to 0.66 in 2024, then fell by 4.12% to 0.63 in 2025, then declined by 6.81% to 0.59 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.59 (Q2 2026), 0.6 (Q1 2026), and 0.63 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn 0.43
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 0.41
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 0.59
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn 0.85
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 0.44
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 0.23
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 0.67
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 0.43
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn 0.73
10 RedHill Biopharma 178.79 Mn 178.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.59
Mar 31, 2026 0.60
Dec 31, 2025 0.63
Sep 30, 2025 0.65
Jun 30, 2025 0.67
Mar 31, 2025 0.68
Dec 31, 2024 0.66
Sep 30, 2024 0.68
Jun 30, 2024 0.72
Mar 31, 2024 0.74
Dec 31, 2023 0.77
Sep 30, 2023 0.78
Jun 30, 2023 0.81
Mar 31, 2023 0.80
Dec 31, 2022 0.81
Sep 30, 2022 0.79
Jun 30, 2022 0.73
Mar 31, 2022 0.76
Dec 31, 2021 0.76
Sep 30, 2021 0.74